Diagnosis and treatment of myeloid and lymphoid cell cancers

Details for Australian Patent Application No. 2005232616 (hide)

Owner Transmolecular, Inc.

Inventors Gonda, Matthew A.; Alvarez, Vernon L.

Agent Davies Collison Cave

Pub. Number AU-A-2005232616

PCT Pub. Number WO2005/099774

Priority 60/559,433 06.04.04 US

Filing date 6 April 2005

Wipo publication date 27 October 2005

International Classifications

A61K 49/00 (2006.01) Preparations for testing

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/099774 Priority application(s): WO2005/099774

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005232619-17 beta-acetamide-4-azasteroids as androgen receptor modulators

2005232610-Adjustable tool for cannulated fasteners